Results
Rossari Biotech Q2 Revenue Up 19% to ₹698 Crores
Rossari Biotech reported Q2FY27 consolidated revenue of ₹697.6 crores, a 19% YoY growth, with EBITDA up 20.9% to ₹87.0 crores.
Net working capital improved to 86 days and net debt reduced to ₹221 cror
